Related Experiment Video
Updated: May 7, 2026
10:05
Fast Grid Preparation for Time-Resolved Cryo-Electron Microscopy
Published on: November 6, 2021
4.6K
Radiating Excellence: A Decade of Pioneering Radiotherapy Trials and Collaborative Leadership at Leeds Cancer
F Slevin1, E M Hudson2, A Hockaday2
1Leeds Institute of Medical Research, University of Leeds, Leeds, UK; Department of Clinical Oncology, Leeds Cancer Centre, Leeds, UK.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|October 1, 2025
Summary
Clinical trials units (CTUs) are advancing cancer treatment through innovative radiotherapy technologies and drug combinations. The Leeds Cancer Research UK CTU has successfully led numerous radiotherapy trials, focusing on patient-centered research and multidisciplinary collaboration.
Area of Science:
- Oncology
- Radiotherapy Research
- Clinical Trials
Background:
- Significant advancements in radiotherapy technologies and drug-radiotherapy combinations offer potential for improved cancer treatments.
- Clinical trials are essential for evaluating the efficacy and safety of novel therapeutic approaches.
- Clinical Trials Units (CTUs) play a crucial role in designing and executing these vital studies.
Purpose of the Study:
- To highlight the development and success of a radiotherapy clinical trials portfolio.
- To emphasize the strategies employed by the Leeds Cancer Research UK CTU in advancing radiotherapy research.
- To outline future priorities for impactful clinical trials in radiotherapy.
Main Methods:
- Development of a comprehensive portfolio of radiotherapy clinical trials over a decade.
- Focus on novel drug-radiotherapy combinations, advanced radiotherapy technologies, and dose optimization.
- Emphasis on multidisciplinary collaboration, translational science engagement, and patient-centered research.
Main Results:
- Established a successful flagship portfolio of radiotherapy clinical trials.
- Demonstrated the importance of collaboration, career development, funding strategy, and patient engagement.
- Built a strong foundation for future impactful radiotherapy research.
Conclusions:
- The Leeds Cancer Research UK CTU has a proven track record in delivering successful radiotherapy clinical trials.
- Multidisciplinary collaboration and patient focus are key to advancing radiotherapy research.
- The CTU is poised to continue shaping the radiotherapy research landscape with future trials.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...